Karyopharm Therapeutics Inc. SEC filings KPTI
Karyopharm Therapeutics Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Apr 2, 2015. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 14, 2026 | — |
| EFFECT | Filing | May 14, 2026 | — |
| CORRESP | Letter to the SEC | May 12, 2026 | — |
| CORRESP | Letter to the SEC | May 12, 2026 | — |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| UPLOAD | Letter from the SEC | May 7, 2026 | — |
| SC TO-I/A | Filing | Jul 19, 2024 | — |
| SC TO-I | Filing | Jun 20, 2024 | — |
| EFFECT | Filing | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | Jun 5, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2024 | — |
| SC TO-C | Filing | Apr 8, 2024 | — |
| CORRESP | Letter to the SEC | Apr 3, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2024 | — |
| EFFECT | Filing | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2023 | — |
| EFFECT | Filing | Jan 3, 2023 | — |
| CORRESP | Letter to the SEC | Dec 29, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2022 | — |
| D | Filing | Dec 8, 2022 | — |
| CT ORDER | Filing | Jul 13, 2021 | — |
| CT ORDER | Filing | Apr 19, 2021 | — |
| EFFECT | Filing | Apr 24, 2019 | — |
| CORRESP | Letter to the SEC | Apr 22, 2019 | — |
| POSASR | Filing | Feb 28, 2019 | — |
| CT ORDER | Filing | Aug 20, 2018 | — |
| CT ORDER | Filing | Jun 14, 2018 | — |
| CT ORDER | Filing | Apr 5, 2018 | — |
| EFFECT | Filing | Feb 14, 2018 | — |
| CORRESP | Letter to the SEC | Feb 13, 2018 | — |
| CORRESP | Letter to the SEC | Feb 13, 2018 | — |
| EFFECT | Filing | Dec 1, 2016 | — |
| CORRESP | Letter to the SEC | Nov 29, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2016 | — |
| CT ORDER | Filing | Sep 26, 2016 | — |
| EFFECT | Filing | May 17, 2016 | — |
| CORRESP | Letter to the SEC | May 2, 2016 | — |
| POSASR | Post affective amendment no. 1 to form s-3 | Mar 15, 2016 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KPTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Newton, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1503802
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.